Sensor/Effector Drug Design with Potential Relevance to Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|34|4479-4499

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.34, 2006-12, pp. : 4479-4499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and Oxidation Chemistry of the Catechol Estrogens: Relevance to Estrogen-Related Carcinogenesis and Potential for Drug Design

By  

Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. : 445-451

Bentham Science Publishers

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 461-474

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Drug Design for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2811-2823

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges of Cancer Drug Design A Drug Metabolism Perspective

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 1-32

Bentham Science Publishers

Access to resources Recommend Favorite